FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer 25% Dextrose Injection Recall

25% Dextrose Injection, USP 2

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Dec 18, 2019
Recall ID
D-0577-2020
Check your lot numberHow we source this data

Summary

Pfizer recalled 25% Dextrose Injection starting Nov 27, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0577-2020 on Dec 18, 2019. Reason: Labeling: Incorrect or Missing Lot and/or expiration date. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or expiration date.

Product description

25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10

Lot numbers, UPCs & expiration codes

Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.

Where it was sold

Nationwide within the United States including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0577-2020
Classification
Class II
Status
Terminated
Recall initiated
Nov 27, 2019
FDA report date
Dec 18, 2019
Quantity
77,100 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-0577-2020, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
84366
Address
235 E 42nd St
Code information
Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.
Postal code
10017-5703
Report date
Dec 18, 2019
Product type
Drugs
Recall number
D-0577-2020
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
77,100 syringes
Termination date
Jan 14, 2022
Reason for recall
Labeling: Incorrect or Missing Lot and/or expiration date.
Voluntary / mandated
Voluntary: Firm initiated
Product description
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
Distribution pattern
Nationwide within the United States including Puerto Rico.
Recall initiation date
Nov 27, 2019
Initial firm notification
Letter
Center classification date
Dec 6, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0577-2020, published Dec 18, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls